| Case no., author, year | Age, sex | Initial symptom | Initial diagnosis | Hormone | 1st treatment | 2nd treatment | Pathology of PA | Pathology of CP | Positional relation for CP and PA | Follow-up duration/prognosis after surgery |
| 1, Prabhakar et al., 1971 [1] | 29, M | Acromegaly, headache, visual disturbance | PA | GH | Craniotomy | None | GH producing | Adamantinomatous | Separate | 4 days/dead due to diabetes insipidus | 2, Shishikina et al., 1981 [2] | 57, M | Headache, double vision, visual disturbance | CP | PRL (5908 mU/ml) | Craniotomy | Craniotomy | PRL producing | Adamantinomatous | Separate | 10 days/dead due to panhypopituitarism | 3, Wheatley et al., 1986 [3] | 61, M | Headache, visual disturbance, reduced libido | CP | PRL (8180 mU/ml) | Craniotomy | VP shunt | PRL producing | Adamantinomatous | Separate | 2 months/dead due to sudden cardiac arrest | 4, Dong et al., 1986 [4] | 32, F | Acromegaly, amenorrhea, lactation | PA | GH PRL | Transsphenoidal | Craniotomy | GH/PRL producing | Adamantinomatous | Separate | n.d./n.d. | 5, Asari et al., 1987 [5] | 47, M | Visual disturbance | PA | PRL (360 ng/ml) | Transsphenoidal | Craniotomy (3rd craniotomy) | PRL producing | Adamantinomatous | Separate | 11 months/good | 6, Jiang and Cheng, 1987 [6] | 36, M | Visual disturbance | PA | Nonfunctioning | Transsphenoidal | Craniotomy | Nonfunctioning | Adamantinomatous | Separate | n.d./n.d. | 7, Cusimano et al., 1988 [7] | 62, F | Personality change, visual disturbance | CP | PRL (34 ng/ml) | Craniotomy (after VP shunt) | Craniotomy | PRL producing (micro) | Adamantinomatous | Separate | 14 months/dead due to pulmonary embolism | 8, Yoshida et al., 2008 [8] | 29, M | Atrial fibrillation | PA | TSH | Transsphenoidal | None | TSH producing | Adamantinomatous | Encase | n.d./n.d. | 9, Karavitaki et al., 2008 [9] | 50, M | Headache, insomnia, reduced libido | PA | LH, FSH | Transsphenoidal | None | LH/FSH producing | Adamantinomatous | Encase | 4 years/good (no recurrence) | 10, Sargis et al., 2009 [10] | 59, M | Visual disturbance | PA | LH, FSH | Craniotomy | None | LH/FSH producing | Adamantinomatous | Encase | n.d./diabetes insipidus | 11, Moshkin et al., 2009 [11] | 12, M | Partial hypopituitarism | CP | Nonfunctioning | Craniotomy | None | Nonfunctioning | Adamantinomatous | Encase | n.d./n.d. | 12, Gokden and Mrak, 2009 [12] | 47, M | Visual disturbance, headache | PA | Nonfunctioning | Transsphenoidal | None | Nonfunctioning | Adamantinomatous | Encase | 1 year/good (no recurrence) | 13, Jin et al., 2013 [13] | 47, F | Visual disturbance, headache | PA | PRL (111 ng/ml) ACTH (116 pg/ml) | Transsphenoidal | Craniotomy | Nonfunctioning | Adamantinomatous | Separate | 3 months/good (no recurrence) | 14, Finzi et al., 2014 [14] | 75, F | Diplopia | PA | PRL (54 ng/ml) | Transsphenoidal | None | Nonfunctioning | Adamantinomatous | Encase | 10 months/good (no recurrence) | 15, present case | 48, M | Memory disturbance | CP | Nonfunctioning | Craniotomy | Transsphenoidal | Nonfunctioning | Adamantinomatous | Separate | 10 years/good (no recurrence) |
|
|
CP, craniopharyngioma; PA, pituitary adenoma; GH, growth hormone; PRL, prolactin; TSH, thyroid-stimulating hormone; LH, luteinizing hormone; FSH, follicle-stimulating hormone; ACTH, adrenocorticotropic hormone; VP, ventriculoperitoneal; author’s surmise based on reference; n.d., not described. |